For validation, we tested the effect of PR55α on p16 expression in CD18/HPAF pancreatic cancer cells, which harbor a p53P152S mutant thus lacking a functional p53/p21 pathway [34]. Here, CDKN2A is linked to pancreatic neoplasm.